#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Eyal Barad Email
Co-Founder, Director, CEO . Cannabics Pharmaceuticals Inc. - CNBX
How to contact Eyal Barad
Join and see Eyal's contact info for free!Phone
Current Roles
Employees:
24Revenue:
$3.7MAbout
Cannabics Pharmaceuticals Inc. (CNBX) is a U.S public company that has developed a platform which leverages novel drug-screening tools and artificial intelligence to develop cannabinoid-based therapies for cancer that are more precise to a patient's genetic profile. By developing tools to assess effectiveness on a personalized basis, Cannabics is helping to move cannabinoids into the future of cancer therapy. The company's R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and Cancer. Cannabics Pharmaceuticals is traded in the OTCQB US stock exchange, under the trade symbol CNBX. Learn More Here https://youtu.be/mte263r7nFA.Cannabics Pharmaceuticals Inc. - CNBX Address
Bethesda Metro CenterBethesda, MD
United States